The themes Materialise is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Shares of revenue are estimates for FY2025, not figures from a filing.
Magics
Software that prepares 3D models for printing, including repairing designs, arranging parts for a print run and planning printer instructions.
CO-AM
Software that helps manufacturers manage 3D-printing work, from orders and quotes to production schedules, quality checks and machine connections.
Materialise Mimics
Medical software that turns scan data into 3D anatomical models for research, treatment planning and the design of personalized medical devices.
Materialise OrthoView
Software that lets orthopedic surgeons plan procedures by placing digital implant templates on X-ray images.
Patient-specific surgical guides and implants
Devices designed for an individual patient and printed to help surgeons carry out a planned procedure.
Industrial 3D printing services
Printed prototypes and production parts for industries including aerospace, automotive, medical technology and semiconductors.
Materialise develops software for preparing three-dimensional (3D) printing jobs and analyzing medical scans, and runs printing facilities that make industrial parts and patient-specific surgical guides, models and implants. Its medical software helps clinicians turn computed tomography (CT) and magnetic resonance imaging (MRI) scans into 3D anatomy for treatment planning; its factory software helps manufacturers prepare files, plan production and coordinate printers. It earns money from software licenses and support, engineering services, printed medical devices and industrial production services.
Built from Materialise NV’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This company files in EUR. Figures are converted to US dollars at $1.00 = 0.902450 EUR, the current rate, applied to every period alike — so growth and margins are the company’s own and not the exchange rate’s. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
$6.59-5.7%Nov 12 close
Figures through September 30, 2026, from the 6-K filed October 29, 2026
Materialise sells medical planning software and custom surgical guides and implants to hospitals and medical-device companies, plus 3D-printed parts to manufacturers.
Grade A
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 29 quarters of Materialise NV’s grade history. The other 27 go back to May 2018.